Market Place
Sourcing Support
With global goals, Zai Lab offers China reality check
20 Apr 2026 //
FIERCE BIOTECH
Boehringer Ingelheim, Zai Lab Partner On Dll3-Targeting Combo
16 Apr 2026 //
GLOBENEWSWIRE
Zai Lab Partners on Novel DLL3 ADC Zocilurtatug in Combo Trial
01 Apr 2026 //
BUSINESSWIRE
Zai Lab Gets (NMPA) Nod For AUGTYRO In NTRK-Positive Solid Tumors
06 Jan 2026 //
BUSINESSWIRE
Chinese Partnerships Propel Biotech`s Revival
17 Dec 2025 //
BIOSPACE
Zai Lab Starts Phase 1/1b Dosing of ZL-1503 for Atopic Dermatitis
08 Dec 2025 //
BUSINESSWIRE
Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan
24 Oct 2025 //
BUSINESSWIRE
Zai Lab Present Updated Zocilurtatug Pelitecan Data at Confernece
13 Oct 2025 //
BUSINESSWIRE
Amgen-Zai Stomach Cancer Asset Loses OS Benefit in Final Analysis
03 Sep 2025 //
FIERCE BIOTECH
Zai Lab Gets Tivdak Approval for Recurrent Cervical Cancer
01 Sep 2025 //
BUSINESSWIRE
Amgen, Zai Say Stomach Cancer Candidate Hits Phase 3 Mark
01 Jul 2025 //
BIOSPACE
Zai Lab Reports Positive Phase 3 Results for Bemarituzumab
30 Jun 2025 //
BUSINESSWIRE
Zai Lab Presents New Data on ZL-1503 at EAACI Congress 2025
13 Jun 2025 //
BUSINESSWIRE
Zai Lab Presents Positive Phase 1 Data for ZL-1310 at 2025 ASCO
02 Jun 2025 //
BUSINESSWIRE
Zai Lab gets FDA Fast Track for ZL-1310 in Small Cell Lung Cancer
19 May 2025 //
BUSINESSWIRE
Zai Lab Presents Data on Next-Gen Oncology Therapies at AACR 2025
25 Apr 2025 //
BUSINESSWIRE
Zai Lab to Present Phase 1 Trial Data of ADC ZL-1310 at 2025 ASCO
23 Apr 2025 //
BUSINESSWIRE
Zai Lab`s Repotrectinib Supplemental Application Accepted
21 Apr 2025 //
BUSINESSWIRE
Zai Lab Announces Acceptance of BLA for Tivak
12 Mar 2025 //
BUSINESSWIRE
Zai Lab Achieves Milestone In Cervical Cancer Treatment Study
15 Jan 2025 //
BUSINESSWIRE
Zai Lab & MediLink Partner For LRRC15 Antibody-Drug Conjugate
09 Jan 2025 //
BUSINESSWIRE
Argenx & Zai Lab Announce Vyvgart Approval for CIDP in China
11 Nov 2024 //
GLOBENEWSWIRE
BMS partner Zai Lab eyes China filing for KarXT after trial win
29 Oct 2024 //
FIERCE PHARMA
ZL-1310 Shows Promise In Small Cell Lung Cancer Patients
24 Oct 2024 //
BUSINESSWIRE
Zai Lab To Host Webcast On DLL3-Targeted ADC ZL-1310
17 Oct 2024 //
BUSINESSWIRE
Zai Lab To Present ZL-1310 ADC Data At EORTC Symposium 2024
09 Oct 2024 //
BUSINESSWIRE
Zai Lab To Present Preclinical Data Of ZL-1503 For Atopic Dermatitis At EADV
17 Sep 2024 //
BUSINESSWIRE
Zai Lab Gets China Priority Review For Efgartigimod CIDP Submission
14 May 2024 //
BUSINESSWIRE
Zai Lab to Present Data Highlighting ZL-1310
13 Mar 2024 //
BUSINESSWIRE
